"Believe the FDA May Deny sabizabulin EUA" - Veru (VERU) PT Lowered at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright Yi Chen Buy Veru, Inc. (NASDAQ: VERU) price target of $21.00 (from $24.00), following recent FDA AdCom's vote ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
